Batu Biologics Announces the Release of the Starve The Tumor Immunotherapy Blog
Clinical Stage Immuno-Oncology Company Releases Media Platform to Provide Background Information on Lead Technology
Today, Batu Biologics announced the release of the Starve The Tumor Video Blog, a series of informational videos and articles designed to provide background information on our lead therapeutic ValloVax. Batu Biologics’ lead clinical candidate, ValloVax, is a first-in-class placenta derived endothelial cell based vaccine designed to stimulate an immune response against several tumor angiogenesis associated antigens for the treatment of solid tumor carcinomas.
